Politics

Georgia Lawmakers Approve PTSD, Intractable Pain as Qualifying Conditions

Published on March 30, 2018 · Last updated July 28, 2020
Georgia State Capitol Building in Atlanta, Georgia, USA.

Before the gavel fell on this year’s legislative session early Friday, Georgia lawmakers OK’d an expansion to the state’s medical cannabis oil program that will add post-traumatic stress disorder and intractable pain as qualifying conditions.

Attention now turns to Gov. Nathan Deal, a Republican in the final year of his last term. Georgia law gives Deal 40 days to decide whether to sign or veto legislation, or allow it to become law without his name.

The House and Senate adjourned a few minutes after midnight, which used to be considered a hard deadline to end the session. But in recent years, lawmakers have worked beyond it.

The Senate had weeks ago stripped PTSD and intractable pain from the bill, but the House added it back Thursday afternoon.

Senators voted 38-14 in favor of widening the cannabis oil program and establishing a joint study commission to analyze medical marijuana.

The Senate had weeks ago stripped PTSD and intractable pain from the bill, but the House added it back Thursday afternoon as Rep. David Clark gave a fiery speech accusing Lt. Gov. Casey Cagle of being “corrupt” and “playing games” with people’s lives by blocking the program’s expansion, which could save the lives of soldiers suffering after serving their country.

“If you can’t lead the Senate, then you sure can’t lead a state,” said Clark, who served in the U.S. Army in Afghanistan, according to an Atlanta Journal-Constitution report. “There are lives at stake. This isn’t a game. … People are dying.”

Cagle’s spokesman declined to comment.

Hours later, while introducing the new version of the bill, Sen. Matt Brass took to the Senate floor to denounce the comments Clark had made in the House. Brass said Clark had acted like a “child pitching a fit.”

Clark, a former Army Ranger, says those suffering from PTSD who have access to cannabis oil are less likely to turn to highly addictive opioid painkillers.

The Associated Press contributed to this report.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.